KCT0008496RecruitingUnknown
A randomized, controlled, patient- and assessor- blinded, exploratory clinical trial to search the stimulation site for repetitive transcranial magnetic stimulation (rTMS) that improves upper extremity function after stroke
Ministry of Science and ICT0 sites15 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Unknown
- Status
- Recruiting
- Sponsor
- Enrollment
- 15
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20(Year) to o Limit (—)
- Sex
- All
Inclusion Criteria
- •1) Adults over 20 years of age
- •2) Patients more than 3 months after onset of stroke
- •3) Patients with NIHSS score of 1 or more to 20 or less
- •4) After receiving a detailed explanation of the study and fully understanding it, the subject has voluntarily decided to participate and has given written consent to comply with the precautions.
Exclusion Criteria
- •1) Patients with systemic infectious symptoms at the time of participation in clinical trials
- •2) In the case of a person with impaired consent (less than 10 points on the MMSE), who is not accompanied by a guardian
- •3) Those with severe medical conditions such as cardiovascular system, digestive system, respiratory system, endocrine system, etc.
- •4) Other cases where the researcher judges that participation in this clinical trial is not appropriate
- •5) Those who are contraindicated for repetitive transcranial magnetic stimulation
- •A. In the case of metal substances (deep brain stimulation electrodes, cerebral aneurysm clips, cardiac pacemakers, etc.)
- •B. Patients with uncontrolled epilepsy (epilepsy) or mental illness
- •6) Pregnant, lactating women and patients who may become pregnant
- •7) Patients with contraindications to imaging
- •8) Those who have undergone cerebral surgery with past or current medical history
Investigators
Similar Trials
Completed
Not Applicable
ANTICS: Antibiotic implant in cardiac surgeryTopic: CardiovascularSubtopic: Cardiovascular (all Subtopics)Disease: CardiovascularInjury, Occupational Diseases, PoisoningSternal wound infectionISRCTN57443262Plymouth Hospitals NHS Trust (UK)200
Active, not recruiting
Not Applicable
A prospective, controlled, randomized, patient and evaluator blinded study to evaluate pain and further disabling complications in patients undergoing Lichtenstein technique for primary inguinal hernia repair by fixing the mesh with TISSUCOL/TISSEEL fibrin sealant versus sutures. - TIMELI 001nilateral, uncomplicated primary inguinal hernia repairClassification code 10022020EUCTR2005-002741-39-DKniversità di Milano, Dipartimento di Scienze Chirurgiche, Ospedale Maggiore Policlinico, Padiglione328
Active, not recruiting
Phase 1
A prospective, controlled, randomized, patient and evaluator blinded study to evaluate pain and further disabling complications in patients undergoing Lichtenstein technique for primary inguinal hernia repair by fixing the mesh with TISSUCOL/TISSEEL fibrin sealant versus sutures.EUCTR2005-002741-39-ESPr Giampiero CAMPANELLI - Ospedale Maggiore Policlinico, Padiglione Beretta Est328
Active, not recruiting
Phase 1
A prospective, controlled, randomized, patient and evaluator blinded study to evaluate pain and further disabling complications in patients undergoing Lichtenstein technique for primary inguinal hernia repair by fixing the mesh with fibrin sealant versus sutures. - TIMILI 001EUCTR2005-002741-39-GBProf. Giampiero CAMPANELLI328
Active, not recruiting
Phase 1
Clinical research study to learn about the effect and safety of different doses of FE 999302 when given as a single dose for final development of the eggs after ovarian stimulatioMedDRA version: 20.1Level: LLTClassification code 10016398Term: Female infertilitySystem Organ Class: 100000004872InfertilityEUCTR2022-000753-80-DKFerring Pharmaceuticals A/S500